STOCK TITAN

December 2021 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 22 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of December 2021 Every stock ranked by its December 2021 gain, with or without news

100

Ranked drops

-89.87%

Largest, ALLK

97.0%

Below baseline, day +5

3.6%

Median recovered, day +5

Filter and sort
Rows

100 ranked drops in December 2021

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 ALLK -89.87% against the close of 12/21/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from the KRYPTOS Study in Patients with Eosinophilic Gastrointestinal Diseases

19:14 ET after hours

2 ADGI -78.81% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against Omicron SARS-CoV-2 Variant

07:00 ET premarket

3 CABA -73.14% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cabaletta Bio Reports Top-line Biologic Activity Data from Two Lowest Dose Cohorts in DesCAARTes™ Trial in Patients with Mucosal Pemphigus Vulgaris

07:00 ET premarket

4 BBIO -71.98% against the close of 12/23/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study

07:00 ET premarket

5 BYSI release reads positive -61.39% against the close of 11/30/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Release reads positive, stock fell 61.39% BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)

08:00 ET premarket

6 NISN under $25M today -60.29% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Nisun International Prices $77 Million Underwritten Public Offering of Common Shares and Pre-Funded Warrants to Purchase Common Shares

08:40 ET premarket

7 TANH under $25M today -57.00% against the close of 12/01/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Tantech Announces Proposed Underwritten Public Offering of Common Shares

17:23 ET after hours

8 GBIO release reads positive -56.91% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 56.91% Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program

06:30 ET premarket

9 BOLT under $25M today release reads positive -55.81% against the close of 12/03/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 55.81% Bolt Biotherapeutics Reports Interim BDC-1001 Phase 1/2 Data Demonstrating a Safe and Well-tolerated Profile and Emerging Clinical Activity at the ESMO Immuno-Oncology Congress 2021

06:00 ET premarket

10 CELZ under $25M today -53.96% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market

04:00 ET premarket

11 RENN More than one ranked move this month 2+ ranked moves -53.36% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Renren Inc. Provides Update on Proposed Settlement re Shareholder Derivative Action

13:31 ET intraday

12 ALDX -50.91% against the close of 12/20/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aldeyra Therapeutics Announces Top-Line Results from the Phase 3 TRANQUILITY Trial in Dry Eye Disease

16:05 ET after hours

13 DBVT -48.52% against the close of 12/20/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement DBV Technologies Provides Update on Investigational Viaskin™ Peanut

16:15 ET after hours

14 SMMT -47.99% against the close of 12/17/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile Infection

08:30 ET premarket

15 RETA -46.51% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Reata Pharmaceuticals Announces Outcome of FDA Advisory Committee Meeting of Bardoxolone for the Treatment of Patients with Chronic Kidney Disease Caused by Alport Syndrome

17:50 ET after hours

16 EVBG -45.39% against the close of 12/09/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Everbridge Announces CEO Transition

16:05 ET after hours

17 RDUS -44.30% against the close of 12/07/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Radius Announces Results from the wearABLe Trial Evaluating Abaloparatide Transdermal System in Postmenopausal Women with Osteoporosis

09:00 ET premarket

18 XFOR release reads positive -44.13% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 44.13% X4 Pharmaceuticals Presents New Clinical Data at ASH 2021 Further Supporting Potential of Mavorixafor + Ibrutinib to Treat Patients with Double-Mutation Waldenström’s Macroglobulinemia

09:00 ET premarket

19 APTO under $25M today -43.08% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement HM43239 Demonstrates Durable Clinical Benefit in Acute Myeloid Leukemia

16:30 ET after hours

20 DOCU release reads positive -42.22% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads positive, stock fell 42.22% DocuSign Announces Third Quarter Fiscal 2022 Financial Results

16:05 ET after hours

21 AEI More than one ranked move this month 2+ ranked moves -41.65% against the close of 12/03/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Alset EHome International Inc. Prices $30 Million Underwritten Public Offering

21:10 ET after hours

22 ESPR -41.47% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Esperion Announces Proposed Public Offering

17:00 ET after hours

23 IGMS -41.31% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results IGM Biosciences Presents Clinical Data from IGM-2323 in Patients with Advanced B Cell Malignancies at 2021 American Society of Hematology Annual Meeting

13:31 ET intraday

24 XCUR under $25M today -40.68% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus

17:36 ET after hours

25 CTMX -40.00% against the close of 12/20/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results CytomX Therapeutics Announces Preliminary Results for Ongoing Phase 2 Expansion Study of CX-2029, a First-in-Class Antibody-Drug Conjugate Candidate Targeting the Transferrin Receptor, CD71

16:05 ET after hours

26 ABEO -39.97% against the close of 12/16/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Abeona Therapeutics Announces Public Offering of Common Stock and Warrants

16:01 ET after hours

27 AGLE -36.50% against the close of 12/03/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aeglea BioTherapeutics Announces Achievement of Primary Endpoint in Phase 3 Study of Pegzilarginase in Patients with Arginase 1 Deficiency

06:30 ET premarket

28 AVCT Also on the opposite board this month release reads positive on both boards -35.81% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Release reads positive, stock fell 35.81% ConnX Expands Long-Standing Partnership with Kandy, Rolling Out Work from Everywhere Solutions for Large, Distributed Retailers

18:31 ET after hours

29 INNV -35.64% against the close of 12/22/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change InnovAge Announces Audit Sanctions In Colorado And Withdraws Guidance

07:09 ET premarket

30 CD -32.88% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Chindata Group Announces Leadership Change

10:04 ET intraday

31 ATAI -31.94% against the close of 12/14/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support by Entering into Extended, Voluntary Share Lock-up Agreements

06:57 ET premarket

32 PULM under $25M today -31.58% against the close of 12/14/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Pulmatrix Announces $6.75 Million Registered Direct Offering

08:00 ET premarket

33 IRNT -31.47% against the close of 12/15/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings IronNet Reports Third Quarter Fiscal 2022 Financial Results

16:15 ET after hours

34 BDR -30.80% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Blonder Tongue Announces Receipt of Notice of Delisting from NYSE American - Common Stock Expected to Continue Trading on NYSE American During Appeal Process

17:30 ET after hours

35 AGIL -30.40% against the close of 12/21/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution AgileThought, Inc. Announces Pricing of $25 Million Public Offering of Class A Common Stock

07:30 ET premarket

36 QURE -29.60% against the close of 12/15/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results uniQure Announces Clinical Update on First Patients in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

07:00 ET premarket

37 AQST -29.26% against the close of 12/20/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Aquestive Therapeutics Receives Notification from FDA that It Will Not Be Ready to Take Action by December 23, 2021 for the Company’s NDA for Libervant™ (diazepam) Buccal Film

22:49 ET after hours

38 SWBI release reads positive -28.72% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads positive, stock fell 28.72% Smith & Wesson Brands, Inc. Reports Second Quarter Fiscal 2022 Financial Results

16:05 ET after hours

39 CURV -27.92% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Torrid Reports Third Quarter Fiscal 2021 Results

16:05 ET after hours

40 ARQQ -27.64% against the close of 12/03/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Arqit Sets Fiscal Year-End 2021 Conference Call for Thursday, December 16, 2021 at 10:30 ET

13:07 ET intraday

41 CDTX -27.61% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Cidara Therapeutics and Mundipharma Announce Positive Topline Results from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

07:00 ET premarket

42 MESO -27.60% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Update on Novartis Agreement

19:18 ET after hours

43 AVAV -27.48% against the close of 12/06/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AeroVironment, Inc. Announces Second Quarter Results and Resets Guidance for Fiscal 2022

10:14 ET intraday

44 ASPU -27.20% against the close of 12/14/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Aspen Group Reports Revenue of $18.9 million, or 12% Growth, for Second Quarter Fiscal 2022

16:01 ET after hours

45 CTIC -27.11% against the close of 11/30/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory CTI BioPharma Announces Extension of FDA Review Period for Pacritinib in Myelofibrosis with Severe Thrombocytopenia

17:30 ET after hours

46 PME -26.66% against the close of 12/28/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Pingtan Marine Enterprise Announces Results of Annual General Meeting

08:30 ET premarket

47 NM -26.51% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Navios Maritime Holdings Inc. Announces $550 Million of Debt Financing

08:52 ET premarket

48 ASAN -26.40% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Asana Announces Record Third Quarter Fiscal 2022 Revenues; Surpasses $100 Million Quarterly Revenues

16:05 ET after hours

49 DOMO -25.92% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Domo Announces Third Quarter Fiscal 2022 Financial Results

16:05 ET after hours

50 CAMP -25.78% against the close of 12/21/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CalAmp Reports Third Quarter Fiscal Year 2022 Financial Results

16:05 ET after hours

51 REVG -25.49% against the close of 12/14/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Rev Group, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Results Provides Fiscal 2022 Full Year Guidance

07:00 ET premarket

52 EFOI under $25M today Also on the opposite board this month on both boards -25.32% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Energy Focus, Inc. Announces $4.5 Million Private Placement Priced At-the-Market under Nasdaq Rules

08:34 ET premarket

53 IDRA -25.28% against the close of 12/14/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Idera Pharmaceuticals Announces Tilsotolimod Updates

16:32 ET after hours

54 ANGN -25.21% against the close of 12/09/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surgery-Associated Acute Kidney Injury

16:05 ET after hours

55 KIRK -24.78% against the close of 12/01/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Kirkland's Reports Third Quarter 2021 Results

07:00 ET premarket

56 OP -24.77% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership OceanPal Inc. Announces New Short Term Contract for m/v Calipso

09:10 ET premarket

57 HQY -24.60% against the close of 12/06/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings HealthEquity Reports Third Quarter Ended October 31, 2021 Financial Results

16:01 ET after hours

58 ALXO -24.20% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results ALX Oncology Announces Initial Data from ASPEN-02, the Ongoing Phase 1 / 2 Study of Evorpacept in Combination with Azacitidine, Demonstrating Safety and Preliminary Activity in Patients with Myelodysplastic Syndrome

09:00 ET premarket

59 PT under $25M today -24.00% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance PINTEC Receives NASDAQ Notification Regarding Minimum Bid Price Compliance

16:30 ET after hours

60 SFIX -23.91% against the close of 12/07/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Stitch Fix Announces First Quarter Fiscal Year 2022 Financial Results

16:03 ET after hours

61 TRIT -22.45% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Triterras Provides Further Update on Independent Audit of Financials for Fiscal Year Ended February 28, 2021

17:19 ET after hours

62 LGVN under $25M today -22.20% against the close of 11/30/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Longeveron Inc. Announces Pricing of a $20.5 Million Private Placement

03:16 ET premarket

63 DIDI -22.18% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement DiDi Announces Recent Developments

20:06 ET after hours

64 PL -22.13% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Planet Reports Financial Results for Third Quarter of Fiscal 2022

16:05 ET after hours

65 BXRX -21.92% against the close of 12/27/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Baudax Bio Announces $4.2 Million Registered Direct Offering

08:00 ET premarket

66 COR -21.87% against the close of 12/27/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation

08:54 ET premarket

67 ALLO -21.74% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Allogene Therapeutics Reports Positive Phase 1 Data from the ALPHA Trials in Non-Hodgkin’s Lymphoma at the 63rd Annual Meeting of the American Society of Hematology

10:30 ET intraday

68 QTT -21.35% against the close of 12/01/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Qutoutiao Inc. Announces Plan to Implement ADS Ratio Change

06:00 ET premarket

69 PHR -21.19% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Phreesia Announces Fiscal Third Quarter 2022 Results

16:05 ET after hours

70 FIGS -21.04% against the close of 12/09/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change FIGS Announces Retirement of Chief Financial Officer, Jeffrey Lawrence; FIGS’ Longtime Senior Vice President of Finance and Strategy, Daniella Turenshine, Appointed as Chief Financial Officer

06:30 ET premarket

71 OCC -20.96% against the close of 12/17/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings OPTICAL CABLE CORPORATION REPORTS FISCAL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS

08:00 ET premarket

72 PYXS -20.92% against the close of 12/03/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Arrakis Therapeutics Appoints James Mutamba, PhD, as Chief Business Officer

08:00 ET premarket

73 ATNF -20.85% against the close of 11/30/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results 180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 International Dupuytren Symposium, Including Top Line Data From the Phase 2b Clinical Trial

14:45 ET intraday

74 ACAD -20.82% against the close of 12/20/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Acadia Pharmaceuticals Announces Plan for a Resubmission of its Supplemental New Drug Application to U.S. FDA for NUPLAZID® (pimavanserin)

16:05 ET after hours

75 QD -20.71% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Qudian Inc. Reports Third Quarter 2021 Unaudited Financial Results

05:00 ET premarket

76 GRAB -20.53% against the close of 12/01/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Grab to Trade on Nasdaq Following Successful Business Combination with Altimeter

16:05 ET after hours

77 OLLI -20.47% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Ollie’s Bargain Outlet Holdings, Inc. Reports Third Quarter Fiscal 2021 Financial Results

16:05 ET after hours

78 MTCR -20.19% against the close of 12/23/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Metacrine Announces Resignation of Chief Medical Officer

08:00 ET premarket

79 CNTX -19.97% against the close of 12/01/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Context Therapeutics Inc. Announces $31.25 Million Private Placement

18:30 ET after hours

80 ICCM under $25M today -19.39% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution IceCure Medical Ltd. Announces Pricing of $15 Million Underwritten Public Offering

08:30 ET premarket

81 MESA -19.21% against the close of 12/09/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Mesa Air Group Reports Fourth Quarter and Full-Year Fiscal 2021 Results

16:01 ET after hours

82 BRDS -19.18% against the close of 12/15/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Latest Estimates Indicate Bird Shared Micro-Electric Vehicles Pump $100M into Cities Worldwide and Save 1.1M Gallons of Gasoline in 2021

09:04 ET premarket

83 VRA -18.79% against the close of 12/07/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Vera Bradley Announces Third Quarter Fiscal Year 2022 Results

08:00 ET premarket

84 AEI More than one ranked move this month 2+ ranked moves -18.66% against the close of 12/01/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Alset International Limited Completes Seeding of the First 30 Rental Homes to American Home REIT Inc.

08:45 ET premarket

85 ENOB -18.64% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors

07:00 ET premarket

86 WBEV More than one ranked move this month 2+ ranked moves -18.53% against the close of 11/30/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Winc to Report Third Quarter 2021 Financial Results on December 8, 2021

16:05 ET after hours

87 SESN -17.58% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™

08:00 ET premarket

88 RENN More than one ranked move this month 2+ ranked moves -17.41% against the close of 12/10/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Renren Inc. Provides Update on Court Order Denying Proposed Settlement re Shareholder Derivative Action

07:00 ET premarket

89 STRM under $25M today -17.39% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Streamline Health® Reports Fiscal Third Quarter 2021 Financial Results

16:15 ET after hours

90 QDEL -17.35% against the close of 12/22/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

07:00 ET premarket

91 WBEV More than one ranked move this month 2+ ranked moves -17.10% against the close of 12/13/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Winc Sees Unprecedented Growth in Its Organic Wines

08:30 ET premarket

92 AIP -17.08% against the close of 11/30/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Arteris Announces Financial Results for the Third Quarter 2021 and Estimated Fourth Quarter and Full Year 2021 Guidance

16:05 ET after hours

93 PSTI -17.01% against the close of 12/23/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19

07:00 ET premarket

94 CORT -16.91% against the close of 12/07/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Corcept Therapeutics Announces Extension of Previously Announced Tender Offer

08:00 ET premarket

95 KRKR under $25M today -16.79% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings 36Kr Holdings Inc. to Report Third Quarter 2021 Financial Results on Thursday, December 9, 2021

07:20 ET premarket

96 PPIH -16.72% against the close of 12/08/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Perma-Pipe International Holdings, Inc. Announces its Third Quarter and Year-to-Date Fiscal 2021 Financial Results

16:04 ET after hours

97 RLX Also on the opposite board this month on both boards -16.70% against the close of 12/02/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings RLX Technology Announces Unaudited Third Quarter 2021 Financial Results

05:30 ET premarket

98 BIRD -16.53% against the close of 11/30/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Allbirds Reports Third Quarter 2021 Financial Results

16:05 ET after hours

99 FLXS -16.45% against the close of 12/15/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Flexsteel Industries, Inc. Provides Business Update for Fiscal Second Quarter 2022

16:10 ET after hours

100 BVXV Also on the opposite board this month on both boards -16.19% against the close of 12/23/2021 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution BiondVax Announces Pricing of $9.0 million Follow-on Underwritten Offering of American Depositary Shares

06:45 ET premarket

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 247 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

4 candidate events for this board could not be anchored to a trading session and are not listed.

2 events were left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

5 events were left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In December 2021, the median decliner had recovered 3.6% of its drop five sessions later; the largest catalyst group was Earnings, 33 of the 100 events, at a median of -23.9%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still below the pre-news close at day +5
Earnings 33 33.0% -23.9% -23.1% 97.0% of 33
Clinical Trial Results 18 18.0% -40.7% -37.6% 100.0% of 18
Other Announcement 17 17.0% -25.3% -23.1% 94.1% of 17
Offering / Dilution 14 14.0% -31.0% -36.2% 100.0% of 14
FDA & Regulatory 5 5.0% Fewer than 10 events in this group, so no figures are shown.

6 other catalyst types, 13 events: Leadership Change, M&A / Acquisition, Contract / Partnership, Uplisting / Compliance, Reverse Merger / Shell, Guidance Change.

How much of the drop held

Horizon Still below the pre-news close close to close Median change since the measured close as a share of the drop
Day +1 100.0% of 100 2.7% recovered, of 100
Day +5 97.0% of 100 3.6% recovered, of 100
Month end 97.0% of 100 1.5% recovered, of 100
Month end falls before day +5 for 7 of these 100 events, so this row is not a later horizon than the one above it.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside December 2021

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsLargest drop
RENN 2Other Announcement -53.36%
AEI 2Offering / Dilution, Other Announcement -41.65%
WBEV 2Earnings, Other Announcement -18.53%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsLargest drop
FLGC 2021-11, 2021-09 -41.19%
AVIR 2021-11, 2021-10 -65.96%
DVAX 2021-11, 2021-09 -22.16%
ABSI 2021-11, 2021-09 -21.08%
NMTC 2021-10, 2021-09 -29.37%
SGBX 2021-10, 2021-09 -23.96%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market48.0%
  • Intraday7.0%
  • After hours45.0%

Volume against normal

  • Under 5x17 events, 17.5%
  • 5x to 20x55 events, 56.7%
  • Over 20x25 events, 25.8%

3 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

  • Pharmaceutical Preparations24 events, 24.0%
  • Biological Products, (no Diagnostic Substances)5 events, 5.0%
  • Services-prepackaged Software4 events, 4.0%
  • Apparel & Other Finishd Prods of Fabrics & Similar Matl2 events, 2.0%
  • Biological Products, (no Disgnostic Substances)2 events, 2.0%
  • Real Estate2 events, 2.0%

22 other industries, 23 events

Industry not known: 38.0%

7 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against November 2021

100 events in the comparable window.

November 2021 median -27.4%, selected from the 12,428 events in that month's eligible pool

December 2021 median -25.6%, 1.8 points shallower than November 2021. December 2021's median is taken over the 100 ranked rows, selected from the 7,751 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.